GSK3B and breast carcinoma: Furthermore, GSK-3β can influence cancer cell apoptosis, as demonstrated in MCF7 breast cancer cells where trichostatin A, a histone deacetylase inhibitor (HDACI), induces apoptosis through GSK-3β activation [41].